The current clinical approaches in PCa diagnosis include digital rectal examination (DRE), prostate-specific antigen (PSA) measurement, imaging (transrectal ultrasound and multiparametric magnetic resonance imaging of the prostate) and prostate biopsies [23]. This evidence concerns the gene KLK3 and posterior cortical atrophy.